抗肥満処方薬市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00020942
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市場紹介 肥満は公衆衛生上の問題であり、体内の過剰または異常な脂肪の蓄積を伴う遺伝的および慢性代謝性疾患でもあります。高血圧、心血管疾患、糖尿病、換気不全、閉塞性睡眠時無呼吸症候群、がんなどの慢性疾患は肥満と関連しています。子どもと大人の間で肥満が増加していることは脅威であり、発展途上国にとっても人口の長寿と健康関連費用に大きな影響を与えています。 市場のダイナミクス 人々の運動習慣の減少、製品開発、肥満人口の増加につながるライフスタイルの変化により、近い将来、抗肥満薬の需要が高まると予想されます。ただし、代替療法の利用可能性と抗肥満薬の副作用の可能性により、市場の成長が妨げられると予想されます。 市場範囲 「2031 年までの抗肥満処方薬市場分析」は、世界市場動向分析に特に焦点を当てたヘルスケア業界の専門的で詳細な調査です。このレポートは、薬物クラス、作用機序、流通チャネルごとに詳細な市場分割を行い、抗肥満処方薬市場の概要を提供することを目的としています。抗肥満処方薬市場は、予測期間中に高い成長が見込まれると予想されます。このレポートは、抗肥満処方薬市場の主要企業の市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。 市場セグメンテーション 抗肥満処方薬市場は、薬剤クラス、作用機序、流通チャネルに基づいて分割されています。薬物クラスに基づいて、市場はブプロピオンとナルトレキソン、オルリスタット、ロルカセリン、フェンテルミンとトピラメート、リラグルチドに分類されます。作用機序に基づいて、市場は末梢作用薬と中枢作用薬に分類されます。流通チャネルごとに、市場は病院薬局、小売薬局、オンライン薬局に分類されます。 このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた抗肥満処方薬市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、中南米。各地域別の抗肥満処方薬市場は、後でそれぞれの国とセグメントごとにサブセグメント化されます。このレポートは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会をカバーしています。レポートは、抗肥満処方薬市場に影響を与える需要と供給の両方の要因を分析し、予測期間中に市場に影響を与える市場ダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、中南米は、これらの地域の抗肥満処方薬市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。 市場関係者 このレポートでは、有機的および無機的な成長戦略として、抗肥満処方薬市場の主要な発展について取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略は、買収、パートナーシップとコラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。抗肥満処方薬市場の市場プレーヤーは、世界市場での抗肥満処方薬の需要の高まりに伴い、将来的に有利な成長の機会があると予想されています。以下は、抗肥満処方薬市場に従事する数社のリストです。レポートには、抗肥満処方薬市場の主要企業のプロフィールとSWOT分析および市場戦略も含まれています。さらに、このレポートは、企業概要、成分と薬剤クラス、作用機序、提供する流通チャネル、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を含む業界の主要企業に焦点を当てています。
    • ブリストルマイヤーズ スクイブ社 • 武田薬品工業 • エーザイ株式会社 • グラクソスミスクライン PLC • ファイザー株式会社 •  SHIONOGI USA INC •  VIVUS INC •  ZAFGEN INC • ノルジン BV • ベーリンガーインゲルハイム GMBH.
Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供しています。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR in Anti-Obesity Prescription Drugs Market?

The market is expected to register a CAGR of 26% during 2021–2031.

What are driving factors impacting the Anti-Obesity Prescription Drugs Market?

The driving factors of the market are the global growth in obesity prevalence rates, developments in the formulation of effective drugs, and rising awareness about obesity-related diseases such as diabetes and heart problems.

What are the future trends of Anti-Obesity Prescription Drugs Market?

Key trends in the market include combination drugs, personalized weight loss medicines, and the increasing use of non-invasive treatments such as oral and injectable drugs.

Which are leading players in Anti-Obesity Prescription Drugs Market?

Key companies in this market are - Novo Nordisk (Saxenda), Eli Lilly (Wegovy), and Johnson & Johnson.

What are the deliverable formats of the Anti-Obesity Prescription Drugs Market?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. BRISTOL-MYERS SQUIBB CO.
2. TAKEDA PHARMACEUTICAL
3. EISAI COMPANY
4. GLAXOSMITHKLINE PLC
5. PFIZER INC
6. SHIONOGI USA INC
7. VIVUS INC
8. ZAFGEN INC
9. NORGINE BV
10. BOEHRINGER INGELHEIM GMBH.
11. 7TM PHARMA
12. ZYDUS CADILA
13. AKRIMAX PHARMACEUTICALS
14. ZEALAND PHARMA
15. ARROWHEAD RESEARCH

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.